Nokea
Beta-blockers decrease triglyceride levels and increase levels of HDL cholesterol.
- A. TRUE
- B. FALSE
Correct Answer: B
Rationale: Beta-blockers typically increase triglycerides and decrease HDL cholesterol, opposite to the statement.
You may also like to solve these questions
The nurse is preparing to administer an intravenous polymyxin antibiotic. The patient reports dizziness along with numbness and tingling of the hands and feet. The nurse will perform which action?
- A. Administer the drug since these are harmless side effects
- B. Hold the drug and notify the provider of these adverse reactions
- C. Obtain an order for an oral form of this medication
- D. Request an order for serum electrolytes
Correct Answer: B
Rationale: Polymyxin neurotoxicity (dizziness, numbness) warrants holding and reporting; these aren't harmless , and it's not oral . Polymyxins can cause nephrotoxicity and neurotoxicity.
Which of the following is corresponding to the following statement: this drug is used for diabetes mellitus and while using there is an increased risk of pancreatitis:
- A. Miglitol
- B. Pioglitazon
- C. Exenatide
- D. Glimepiride
Correct Answer: C
Rationale: Exenatide, a GLP-1 agonist, treats diabetes and has a known risk of pancreatitis as a rare but serious side effect.
Choose the correct statement about ondansetron:
- A. It is a dopamine D2 receptor antagonist
- B. It suppresses postoperative nausea and vomiting
- C. It is the most effective antiemetic for motion sickness
- D. It is not effective by oral route
Correct Answer: B
Rationale: Ondansetron, a 5-HT3 receptor antagonist, effectively suppresses postoperative nausea and vomiting; it's less effective for motion sickness and is effective orally.
Corticosteroids are acting on:
- A. Ion channels
- B. Thirosinkinase
- C. G-proteins
- D. genome and cases gene transcription
Correct Answer: D
Rationale: Corticosteroids act on the genome, binding to receptors that regulate gene transcription.
The U.S. Food and Drug Administration regulates:
- A. Prescribing of drugs by MDs and NPs
- B. The official labeling for all prescription and over-the-counter drugs
- C. Off-label recommendations for prescribing
- D. Pharmaceutical educational offerings
Correct Answer: B
Rationale: The FDA regulates drug labeling , not prescribing practices , off-label use , or education , which fall under state or professional domains.